NCT04402606Completed
Study on Skin Toxicities Induced by Cancer Treatments
DERMACLIC : Study on Skin Toxicities Induced by Cancer Treatments
Source: ClinicalTrials.gov · Last updated 18 Apr 2024
Brief summary (registry, in English)
The skin toxicities will be evaluated on patient (male or female) with an indication of cancer treatment in the case of solid tumor of the breast, or lung.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 292 (actual)
- First submitted
- 29 Apr 2020
- Start date
- 25 Nov 2020
- Primary completion date
- 25 Nov 2020
- Lead sponsor
- Institut Curie
- Diseases
- Lung cancer
- NCT number
- NCT04402606
What you commit to
- Study type: Interventional
- Participants enrolled: 292
- From 25 Nov 2020 to the primary completion date, 25 Nov 2020
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient receiving anti-tumor treatment with radiotherapy exclusively or associated with concomitant radiotherapy ;
Other illness
- Patient treated for lymphoma, leukemia or inflammatory breast cancer ;
- Patient with a general condition \> 2 at baseline (ECOG classification) ;
Other
- Patient with a solid tumour which location is other than breast or lung;
- Patient with a tumor wound ;
- Patient unable to receive information about the study and to give consent ;
- Persons deprived of liberty or guardianship ;
- Impossible submission to study procedures for geographical or psychological reasons.
Who the study is looking for
- Patient, male or female, aged 18 years and older, with a solid tumor breast or lung, localized, locally advanced or not, metastatic or not;
- Patient in medical oncology consultation requiring systemic anti-tumor therapy (chemotherapy, targeted therapy, hormone therapy, immunotherapy) in neo-adjuvant, adjuvant or metastatic;
- Treatment planned for a minimum period of 3 months (from the date of inclusion);
- Having a social security protection;
- Signed informed consent form of the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut Curie Coordinator of this site? Confirm its status | Paris | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.